These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 9599104

  • 21. A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris.
    Sabatine MS, Januzzi JL, Snapinn S, Théroux P, Jang IK.
    Am J Cardiol; 2001 Sep 01; 88(5):488-92. PubMed ID: 11524055
    [Abstract] [Full Text] [Related]

  • 22. The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial.
    Cohen M, Gensini GF, Maritz F, Gurfinkel EP, Huber K, Timerman A, Krzeminska-Pakula M, Danchin N, White HD, Santopinto J, Bigonzi F, Hecquet C, Vittori L, TETAMI Investigators.
    J Am Coll Cardiol; 2003 Oct 15; 42(8):1348-56. PubMed ID: 14563573
    [Abstract] [Full Text] [Related]

  • 23. Tirofiban. A review of its use in acute coronary syndromes.
    McClellan KJ, Goa KL.
    Drugs; 1998 Dec 15; 56(6):1067-80. PubMed ID: 9878994
    [Abstract] [Full Text] [Related]

  • 24. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease.
    Chesebro JH, Badimon JJ.
    N Engl J Med; 1998 May 21; 338(21):1539-41. PubMed ID: 9593795
    [No Abstract] [Full Text] [Related]

  • 25. [Acute coronary syndromes: an update. I. Pathogenesis and drug therapy].
    Auer J, Berent R, Maurer E, Mayr H, Weber T, Eber B.
    Herz; 2001 Mar 21; 26(2):99-110. PubMed ID: 11349620
    [Abstract] [Full Text] [Related]

  • 26. Benefit of an early invasive management strategy in women with acute coronary syndromes.
    Glaser R, Herrmann HC, Murphy SA, Demopoulos LA, DiBattiste PM, Cannon CP, Braunwald E.
    JAMA; 2002 Dec 25; 288(24):3124-9. PubMed ID: 12495392
    [Abstract] [Full Text] [Related]

  • 27. Effects of tirofiban plus heparin versus heparin alone on troponin I levels in patients with acute coronary syndromes.
    Januzzi JL, Hahn SS, Chae CU, Giugliano R, Lewandrowski K, Theroux P, Jang IK.
    Am J Cardiol; 2000 Oct 01; 86(7):713-7. PubMed ID: 11018188
    [Abstract] [Full Text] [Related]

  • 28. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
    Han Y, Guo J, Zheng Y, Zang H, Su X, Wang Y, Chen S, Jiang T, Yang P, Chen J, Jiang D, Jing Q, Liang Z, Liu H, Zhao X, Li J, Li Y, Xu B, Stone GW, BRIGHT Investigators.
    JAMA; 2015 Apr 07; 313(13):1336-46. PubMed ID: 25775052
    [Abstract] [Full Text] [Related]

  • 29. Effects of enoxaparin and nadroparin on major cardiac events in high-risk unstable angina treated with a glycoprotein IIb/IIIa inhibitor.
    Okmen E, Ozen E, Uyarel H, Sanli A, Tartan Z, Cam N.
    Jpn Heart J; 2003 Nov 07; 44(6):899-906. PubMed ID: 14711185
    [Abstract] [Full Text] [Related]

  • 30. Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding score.
    Hermanides RS, Ottervanger JP, ten Berg JM, Gosselink AT, van Houwelingen G, Dambrink JH, Stella PR, Hamm C, van 't Hof AW, On-TIME 2 Trial Investigators.
    J Invasive Cardiol; 2012 Mar 07; 24(3):84-9. PubMed ID: 22388296
    [Abstract] [Full Text] [Related]

  • 31. Aspirin, heparin, or both to treat acute unstable angina.
    Théroux P, Ouimet H, McCans J, Latour JG, Joly P, Lévy G, Pelletier E, Juneau M, Stasiak J, deGuise P.
    N Engl J Med; 1988 Oct 27; 319(17):1105-11. PubMed ID: 3050522
    [Abstract] [Full Text] [Related]

  • 32. Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.
    Kereiakes DJ, Kleiman NS, Ambrose J, Cohen M, Rodriguez S, Palabrica T, Herrmann HC, Sutton JM, Weaver WD, McKee DB, Fitzpatrick V, Sax FL.
    J Am Coll Cardiol; 1996 Mar 01; 27(3):536-42. PubMed ID: 8606262
    [Abstract] [Full Text] [Related]

  • 33. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA.
    Eur Heart J; 1998 Apr 01; 19 Suppl D():D10-21. PubMed ID: 9597518
    [Abstract] [Full Text] [Related]

  • 34. Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
    Lauer MA, Houghtaling PL, Peterson JG, Granger CB, Bhatt DL, Sapp SK, Simoons ML, Harrington RA, Topol EJ, Lincoff AM, Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators.
    Circulation; 2001 Dec 04; 104(23):2772-7. PubMed ID: 11733393
    [Abstract] [Full Text] [Related]

  • 35. Comparison of bivalirudin monotherapy versus unfractionated heparin plus tirofiban in patients with diabetes mellitus undergoing elective percutaneous coronary intervention.
    Tavano D, Visconti G, D'Andrea D, Focaccio A, Golia B, Librera M, Caccavale M, Ricciarelli B, Briguori C.
    Am J Cardiol; 2009 Nov 01; 104(9):1222-8. PubMed ID: 19840566
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Eptifibatide and tirofiban: new preparations. Limited benefit.
    Prescrire Int; 2000 Oct 01; 9(49):135-8. PubMed ID: 11603412
    [Abstract] [Full Text] [Related]

  • 38. Overview of clinical trials of glycoprotein IIb-IIIa inhibitors in acute coronary syndromes.
    Harrington RA.
    Am Heart J; 1999 Oct 01; 138(4 Pt 2):276-86. PubMed ID: 10502233
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.